We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Novavax Pauses Production of COVID-19 Vaccine to Keep its Government Funding, Pushes EUA Submission to 4th Quarter
Novavax Pauses Production of COVID-19 Vaccine to Keep its Government Funding, Pushes EUA Submission to 4th Quarter
To address concerns of federal regulators, vaccine maker Novavax said it will pause production of its COVID-19 vaccine lest it lose its government funding.